Last reviewed · How we verify
NCT05586412
Efficacy of Auricular Vagus Nerve Stimulation
NA trial testing vagus nerve stimulation in Being in the 18-50 Age Population in 90 participants. Status unknown.
3 November 2022
Quick facts
| Lead sponsor | Inonu University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 7 July 2022 |
| Primary completion | 3 November 2022 |
| Estimated completion | 20 December 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- vagus nerve stimulation
Conditions studied
- Being in the 18-50 Age Population — all drugs for Being in the 18-50 Age Population →
- Being Diagnosed With Frozen Shoulder by a Specialist Physician — all drugs for Being Diagnosed With Frozen Shoulder by a Specialist Physician →
- Volunteer to Participate in the Study — all drugs for Volunteer to Participate in the Study →
Sponsor
Inonu University
Who can join
Adults 18 to 50, any sex, with Being in the 18-50 Age Population or Being Diagnosed With Frozen Shoulder by a Specialist Physician. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Auricular Vagus Nerve Stimulation, a non-invasive method, will be used in the study. Studies have shown that vagus nerve stimulation combined with a large vagal nerve network can have a neuromodulatory effect that will activate some natural protective pathways to improve health. Clinically, vagus nerve stimulation is FDA-approved for epilepsy, treatment-resistant depression, and morbid obesity. Since OSS dysfunction is also involved in the etiology of DO and there is no study on the effectiveness of vagus nerve stimulation in this disease, this study is planned to reveal the effectiveness of auricular vagus nerve stimulation and home exercise program in DO patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05586412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of vagus nerve stimulation
Trials testing the same drug.
- NCT07528742 — Vagus Nerve Stimulation for Reaction Time · NA · recruiting
- NCT06473623 — Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder · NA · recruiting
- NCT07097025 — 2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Re · completed
- NCT04153812 — Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression · Phase 1, PHASE2 · unknown
Other Inonu University trials
Trials by the same sponsor.
- NCT06553807 — Genital Self İmage and Satisfaction With Genital Appearance · NA · not yet recruiting
- NCT07480122 — Motor Imaging, Neglect, and Upper Extremity Function in Stroke · not yet recruiting
- NCT07463326 — The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder · NA · enrolling by invitation
- NCT07510737 — The Effect of Cross Training on Clinical and Functional Outcomes in Frozen Shoulder Rehabilitation · not yet recruiting
- NCT07530211 — The Effect of Systemic Factors on Peri-implant Health Status and Clinical Indices · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05586412 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inonu University
- Last refreshed: 19 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05586412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing